Epithalon vs NAD+: Longevity Research Comparison

In the epithalon vs NAD+ comparison, the two compounds sit in different lanes of longevity research: Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied primarily for its reported relationship to telomerase activity and circadian/pineal signaling, while NAD+ is a naturally occurring redox coenzyme studied for its role in mitochondrial energy metabolism and as a substrate for sirtuin enzymes. Neither is a finished therapeutic, and both are supplied strictly for in-vitro and laboratory research use. This guide lays out where their mechanisms diverge, where research interest overlaps, and how purity, storage, and sourcing differ between a short synthetic peptide and a redox cofactor.

Epithalon and NAD+: Two Different Classes, One Shared Research Question

Cellular-aging research has never converged on a single mechanism, and that fact is on full display when Epithalon and NAD+ are placed side by side. Both compounds are cataloged within longevity and cellular-research programs, both are frequently discussed in the same conversations about aging biology, and both are supplied by Royal Peptide Labs for laboratory investigation. But structurally and mechanistically, they could hardly be more different. Epithalon is a four-amino-acid synthetic peptide; NAD+ is a small-molecule dinucleotide coenzyme found natively in every living cell. One is a laboratory-engineered signaling tool modeled on a naturally occurring pineal tissue peptide; the other is an essential, universally conserved metabolic cofactor whose research interest centers on how its cellular concentration and redox cycling change across biological age.

What unites them is not chemistry but the research question each is used to probe: why do specific cellular functions — telomere maintenance, circadian gene expression, mitochondrial respiratory efficiency, sirtuin-mediated deacetylation — appear to shift as an organism or cell population ages, and can a defined molecule be used as a research tool to interrogate that shift experimentally. Epithalon approaches that question from the direction of genomic stability and clock-gene signaling. NAD+ approaches it from the direction of bioenergetics and enzymatic cofactor availability. Neither approach is more “correct” than the other; they represent distinct, complementary branches of a research field that has not converged on a single unifying mechanism of cellular aging.

Why This Comparison Matters for Study Design

Research teams building a longevity-focused experimental program frequently need to decide which compound — or whether both — belongs in a given protocol. That decision should be driven by the specific pathway under investigation, not by category adjacency on a supplier’s shelf. A study asking about telomerase gene expression in a cultured fibroblast line has little practical use for NAD+ as a primary variable; a study asking about NAD+/NADH ratio and sirtuin deacetylase activity in a mitochondrial-function assay has little practical use for Epithalon as a primary variable. This guide is organized to make that decision easier, working systematically through classification, mechanism, chemistry, purity verification, and handling for both compounds before addressing where the two are more reasonably studied together than apart.

Both compounds are available through Royal Peptide Labs’ longevity and cellular research peptides category, where they sit alongside other compounds relevant to cellular-aging research programs. The remainder of this guide uses each compound’s product listing — the Epithalon 10mg research peptide and the NAD+ 500mg research compound — as the reference point for sourcing and specification questions, while the sections below focus on mechanism, chemistry, and laboratory practice.

What Is Epithalon? Tetrapeptide Classification and Research Origin

Epithalon (also written Epitalon or Epithalone) is classified as a synthetic tetrapeptide with the amino acid sequence alanine-glutamic acid-aspartic acid-glycine (Ala-Glu-Asp-Gly, abbreviated AEDG). It belongs to a broader category of short synthetic peptides developed within a research tradition investigating peptide preparations derived from pineal gland tissue, with Epithalon specifically engineered as a defined, synthesizable analog intended to reproduce the peptide activity attributed to a naturally occurring pineal extract preparation studied in earlier gerontological research programs.

Position Within the Longevity Peptide Category

Within Royal Peptide Labs’ classification system, Epithalon is shelved in the longevity and cellular peptides research category, distinct from growth-hormone-axis peptides, metabolic/incretin peptides, and recovery-focused peptides. That placement reflects its primary research association: investigations into telomerase-related gene expression, chromosomal end-cap (telomere) biology, and circadian/pineal signaling pathways, rather than any metabolic-hormone or tissue-repair mechanism.

Why a Four-Residue Peptide Draws Research Interest

Short peptides like Epithalon occupy an interesting niche in peptide pharmacology research: at only four residues, the molecule is small enough to be chemically stable, inexpensive to synthesize with high purity, and straightforward to verify analytically, while still being large enough to engage specific signaling or regulatory machinery rather than acting as a simple nutrient or buffer component. This size class distinguishes Epithalon from larger signaling peptides (such as growth-hormone secretagogues or incretin-receptor agonists) that rely on defined receptor-binding domains spanning dozens of residues. Because Epithalon’s proposed research relevance centers on gene-regulatory and enzymatic processes inside the cell nucleus rather than on cell-surface receptor engagement, its research questions are framed differently from receptor-pharmacology peptides discussed elsewhere in this research library.

Epithalon Identity Summary

Parameter	Description
Compound class	Synthetic tetrapeptide (short-chain peptide, longevity/cellular-aging research)
Amino acid sequence	Ala-Glu-Asp-Gly (AEDG)
Approximate molecular weight	~390 g/mol
Origin concept	Synthetic analog modeled on a pineal-tissue peptide preparation studied in earlier gerontological research
Primary research association	Telomerase-related gene expression; circadian/pineal signaling
Supplied form	Lyophilized (freeze-dried) powder, research-use-only
Royal Peptide Labs category	Longevity and cellular peptides research

A more detailed treatment of Epithalon’s mechanism, chemistry, and handling is available in the dedicated Epithalon research guide, which this comparison references throughout for readers who want to go deeper on the peptide side of the comparison specifically.

What Is NAD+? Coenzyme Classification and Biochemical Role

Nicotinamide adenine dinucleotide (NAD+) is not a peptide at all — it is a small-molecule dinucleotide, built from two nucleotides joined through their phosphate groups, one bearing an adenine base and the other a nicotinamide base. NAD+ is one of the most fundamental and universally conserved molecules in cellular biochemistry, present in essentially every living cell and required for hundreds of enzymatic reactions. Classifying NAD+ alongside peptide research compounds is a matter of research-program convenience — both are studied under a shared longevity-research umbrella — rather than chemical kinship.

The Redox Cycle: NAD+ and NADH

NAD+’s defining biochemical property is its redox cycling behavior. In its oxidized form (NAD+), the molecule can accept a hydride ion, becoming the reduced form (NADH); this interconversion is the basis of its role as an electron carrier across core metabolic pathways, including glycolysis, the tricarboxylic acid (TCA) cycle, and the electron transport chain that drives oxidative phosphorylation and cellular ATP production. Research characterizing the NAD+/NADH ratio in a given cell population or tissue model is a standard readout used across bioenergetics and mitochondrial-function research, independent of any aging-specific hypothesis.

Beyond Redox: NAD+ as an Enzymatic Substrate

What elevates NAD+ from a purely metabolic cofactor to a central object of longevity research is its second, non-redox role as a consumed substrate (not just a recycled electron carrier) for several enzyme families implicated in cellular-aging research:

Sirtuins (SIRT1–SIRT7) — a family of NAD+-dependent deacetylase and ADP-ribosyltransferase enzymes studied extensively in relation to gene expression regulation, mitochondrial biogenesis signaling, and cellular stress-response pathways.
PARPs (poly-ADP-ribose polymerases) — enzymes involved in DNA damage response signaling that consume NAD+ as a substrate for poly-ADP-ribosylation reactions.
CD38 and related NAD+ glycohydrolases — enzymes that degrade NAD+ and are studied in relation to age-associated changes in cellular NAD+ pool size.

Because these enzymes consume NAD+ rather than merely cycling it between oxidized and reduced states, cellular NAD+ availability functions as a shared, rate-limiting resource across multiple regulatory pathways simultaneously — a property that makes NAD+ pool size itself, not just NAD+/NADH ratio, a research variable of independent interest.

NAD+ Identity Summary

Parameter	Description
Compound class	Small-molecule dinucleotide coenzyme (redox cofactor and enzymatic substrate)
Molecular formula (oxidized form)	C21H27N7O14P2
Approximate molecular weight	~663 g/mol
Origin	Naturally occurring in all living cells; synthesized via de novo and salvage biosynthetic pathways
Primary research association	Mitochondrial redox metabolism; sirtuin, PARP, and CD38 enzymatic substrate availability
Supplied form	Lyophilized/powder research compound, research-use-only
Royal Peptide Labs category	Longevity and cellular peptides research

A fuller treatment of NAD+’s biochemistry, sourcing, and handling is available in the companion NAD+ research guide, which readers focused specifically on the coenzyme side of this comparison may want to consult alongside this article.

Epithalon vs NAD+: Mechanism and Pathway Comparison

The most consequential difference between Epithalon and NAD+ is not their size or chemical class but the biological layer at which each is studied. Epithalon’s proposed research relevance operates largely at the level of gene expression and nuclear/genomic regulation; NAD+’s research relevance operates at the level of metabolic biochemistry and enzymatic substrate availability. Understanding that distinction is the single most useful framing for deciding which compound belongs in a given experimental design.

Epithalon: Telomerase and Circadian Signaling Pathways

Epithalon is studied primarily in connection with two related but distinct research threads. The first concerns telomerase — the ribonucleoprotein enzyme responsible for maintaining telomere length at chromosome ends — and Epithalon’s reported relationship to telomerase gene expression and activity in cultured cell models. The second concerns circadian and pineal signaling, reflecting Epithalon’s origin as an analog of a pineal-tissue peptide preparation; research in this thread examines Epithalon’s relationship to melatonin-associated signaling and circadian gene expression patterns in laboratory models. Both threads are investigated using gene-expression assays (such as qPCR-based measurement of telomerase reverse transcriptase, TERT, expression), telomere-length assays (such as quantitative PCR or Southern blot-based telomere restriction fragment analysis), and, in some research designs, reporter-gene systems for circadian clock genes.

NAD+: Redox Cycling and Sirtuin Substrate Pathways

NAD+ research, by contrast, is organized around biochemical assays measuring NAD+ and NADH concentrations directly (via enzymatic cycling assays, mass spectrometry, or fluorescence-based NAD+/NADH ratio kits), mitochondrial respiratory function assays (such as oxygen consumption rate measurements), and sirtuin enzymatic activity assays that use NAD+ as a required cofactor. Because NAD+ is consumed as a substrate rather than acting through a receptor-mediated signaling cascade, its research relevance is typically expressed in terms of cellular pool size, redox ratio, and downstream enzymatic activity that depends on NAD+ availability, rather than in terms of gene-expression changes triggered by ligand-receptor binding.

Side-by-Side Mechanism Comparison

Parameter	Epithalon	NAD+
Primary research pathway	Telomerase/telomere biology; circadian-pineal signaling	Mitochondrial redox metabolism; sirtuin/PARP/CD38 substrate availability
Proposed mode of relevance	Gene-expression and nuclear-regulatory research target	Metabolic cofactor and enzymatic substrate
Primary cellular compartment of interest	Nucleus (telomeres, gene transcription)	Mitochondria and cytosol (redox reactions, enzymatic substrate pools)
Typical readouts in research assays	TERT/telomerase gene expression; telomere length; circadian clock-gene expression	NAD+/NADH ratio; sirtuin deacetylase activity; mitochondrial oxygen consumption
Receptor-mediated mechanism?	Not the primary framework — gene-regulatory hypothesis, not receptor-ligand binding	Not receptor-mediated — enzymatic substrate/cofactor role
Common model organisms/systems	Cultured human and animal somatic cell lines; some whole-organism models	Cultured cell lines; isolated mitochondria; whole-organism models across multiple species

This table is the fastest way to see why Epithalon and NAD+ are rarely treated as substitutes for one another in a research design: they are answering structurally different biological questions, using different assay technologies, and reporting on different cellular compartments.

Structure and Chemistry: Peptide vs Dinucleotide

Beyond mechanism, Epithalon and NAD+ differ fundamentally in their basic chemistry — a distinction that matters directly for how each compound is synthesized, purified, verified analytically, and handled in a laboratory setting.

Epithalon’s Peptide Architecture

As a four-residue peptide, Epithalon is built through standard solid-phase peptide synthesis (SPPS) chemistry, in which each amino acid residue is added sequentially to a growing chain anchored to a solid resin support, followed by cleavage and purification. Because the sequence is short, synthesis is comparatively straightforward relative to longer signaling peptides, and full-length synthesis yield tends to be high, which supports achieving very high purity specifications for a research-grade product. Epithalon’s four residues — alanine, glutamic acid, aspartic acid, and glycine — are all standard proteinogenic amino acids, meaning no unusual, non-natural residues or post-translational modifications are involved in its structure.

NAD+’s Dinucleotide Architecture

NAD+, by contrast, is not assembled via peptide bond chemistry at all. It consists of two nucleotide units — adenosine monophosphate (AMP) and nicotinamide mononucleotide (NMN) — joined through a pyrophosphate linkage between their respective phosphate groups. This dinucleotide architecture places NAD+ in an entirely separate synthetic and analytical chemistry category from Epithalon: its production for research supply purposes relies on chemical or enzymatic synthesis routes appropriate to nucleotide chemistry, not solid-phase peptide synthesis, and its purification and identity verification rely on chromatographic and spectroscopic methods calibrated to a small, highly polar, charged molecule rather than to a peptide chain.

Physical Properties Compared

Both compounds are typically supplied as lyophilized (freeze-dried) powders for research use, which is standard practice for stabilizing sensitive biomolecules during storage and shipping. Beyond that similarity, their physical behavior diverges: Epithalon, as a short, relatively hydrophilic peptide, dissolves readily in standard aqueous research diluents. NAD+ is also water-soluble but is markedly more sensitive to pH and to enzymatic or non-enzymatic hydrolysis of its pyrophosphate linkage, making solution stability a more active handling consideration for NAD+ than for a stable short peptide like Epithalon.

Structural Comparison Table

Structural Feature	Epithalon	NAD+
Chemical class	Synthetic tetrapeptide	Dinucleotide coenzyme
Building blocks	Four standard amino acids (Ala, Glu, Asp, Gly)	Two nucleotides (AMP + nicotinamide mononucleotide) joined via pyrophosphate linkage
Synthesis route	Solid-phase peptide synthesis (SPPS)	Chemical or enzymatic nucleotide synthesis
Approximate molecular weight	~390 g/mol	~663 g/mol
Key labile bond(s)	Peptide (amide) bonds — comparatively stable for a short chain	Pyrophosphate linkage and glycosidic bonds — more hydrolysis-prone
Supplied physical form	Lyophilized powder	Lyophilized powder

This structural gap — peptide chemistry versus nucleotide chemistry — is the underlying reason the two compounds require different analytical verification approaches and different stability precautions, both of which are covered in detail later in this guide.

Epithalon vs NAD+ at a Glance: Master Comparison Table

For research teams who want a single consolidated reference before diving into the deeper mechanism and handling sections that follow, the table below summarizes the core practical distinctions between the two compounds as supplied for laboratory research.

Category	Epithalon	NAD+
Compound type	Synthetic tetrapeptide	Dinucleotide coenzyme
Royal Peptide Labs category	Longevity and cellular peptides	Longevity and cellular peptides
Product listing	Epithalon 10mg	NAD+ 500mg
Primary research theme	Telomerase/telomere biology, circadian-pineal signaling	Mitochondrial redox metabolism, sirtuin substrate availability
Mechanistic layer studied	Gene expression / nuclear regulation	Enzymatic biochemistry / metabolic cofactor
Typical supplied quantity	Milligram-scale peptide vial	Milligram-scale coenzyme vial (larger per-vial mass typical for small molecules)
Reconstitution sensitivity	Moderate — standard peptide handling practice applies	Higher — pyrophosphate linkage is more hydrolysis-prone
Common comparative research pairing	Studied alongside other short bioregulator peptides (e.g., thymalin-class peptides)	Studied alongside other mitochondrial-support research compounds (e.g., MOTS-c)
Not to be confused with	Growth-hormone secretagogue peptides (different receptor-mediated mechanism entirely)	NAD+ precursor compounds such as NMN or NR, which are metabolized to NAD+ rather than being NAD+ itself

Reading the Table Correctly

The most important row in that table, for study-design purposes, is “mechanistic layer studied.” Epithalon’s research literature is concentrated at the level of gene expression and genomic regulation — outcomes are typically reported as changes in transcript levels, enzymatic activity linked to gene products, or measured telomere length. NAD+’s research literature is concentrated at the level of biochemical substrate availability and enzymatic reaction rate — outcomes are typically reported as changes in metabolite concentration, redox ratio, or downstream enzyme activity that depends directly on substrate presence. A research team unclear on which compound fits a given hypothesis should ask, concretely: is the question about what genes are being expressed and how chromosome ends are being maintained (favors Epithalon-type research), or is the question about how efficiently a cell is running its redox and energy-production chemistry (favors NAD+-type research)?

Research Applications and Model Systems for Each Compound

Both compounds are studied across a range of model systems, but the specific systems favored for each reflect their distinct mechanistic focus. This section surveys the model classes typically used for Epithalon-focused and NAD+-focused research without describing or implying any specific outcome, result, or effect size — those belong in the primary literature, not in a sourcing and handling comparison.

Cell Culture Models

Epithalon research commonly uses cultured somatic cell lines — including human fibroblast lines, which have a long history in telomere and cellular-senescence research because their replicative capacity and telomere shortening behavior in culture are well characterized as a baseline model system. Circadian-focused Epithalon research may additionally use cell lines engineered with clock-gene reporter constructs to track circadian gene expression rhythms in real time. NAD+ research uses a broader range of cell types, since NAD+-dependent metabolism is universal to all cells, but frequently emphasizes cell types with high metabolic or mitochondrial demand — such as neuronal, hepatic, or muscle-derived cell lines — where redox and bioenergetic changes are more readily measured and interpreted.

Isolated Organelle and Cell-Free Systems

NAD+ research has a well-established cell-free and isolated-organelle research tradition that Epithalon research does not share to the same degree — isolated mitochondria preparations are commonly used to study NAD+-dependent electron transport chain function and oxygen consumption directly, without the confounding variables introduced by an intact cell. Cell-free enzymatic assays (for example, purified sirtuin enzyme activity assays using synthetic peptide substrates and NAD+ as a cofactor) are also common in NAD+-focused research. Epithalon research, by contrast, is concentrated almost entirely in intact-cell and whole-organism systems, since its proposed mechanism operates through gene expression, which requires an intact transcriptional and translational cellular machinery to study meaningfully.

Animal and Whole-Organism Models

Both compounds are studied in animal and other whole-organism model systems for questions that require systemic, multi-tissue context that cell culture cannot replicate. Epithalon-focused animal research typically examines circadian behavior patterns, tissue-level telomere length across organ systems, and age-related gene-expression changes at the organismal level. NAD+-focused animal research typically examines tissue NAD+ pool size across organ systems, mitochondrial function in specific tissues (muscle, brain, liver being common focus areas), and downstream physiological correlates of sirtuin pathway activity. This research guide does not describe or summarize outcome data from any such study, consistent with the anti-fabrication standard applied throughout — researchers should consult primary, peer-reviewed sources for outcome-level information.

Comparative Research Model Table

Model Tier	Epithalon Research Use	NAD+ Research Use
Cell-free / isolated enzyme or organelle systems	Uncommon — mechanism requires intact transcriptional machinery	Common — isolated mitochondria, purified sirtuin activity assays
Cultured somatic cell lines	Common — fibroblast and other lines for telomere/gene-expression assays	Common — broad range of cell types for redox/bioenergetic assays
Clock-gene reporter systems	Used for circadian signaling research	Not typically applicable
Animal/whole-organism models	Used for systemic telomere and circadian-behavior research	Used for systemic NAD+ pool and mitochondrial-function research

The Telomere and Circadian Research Angle (Epithalon)

To understand why Epithalon draws sustained research interest, it helps to separate its two distinct threads of investigation rather than treating “longevity peptide” as a single undifferentiated research category.

Telomere Biology as a Research Framework

Telomeres are repetitive nucleotide sequences capping the ends of chromosomes, protecting genomic DNA from degradation and from being misidentified by cellular repair machinery as damaged DNA requiring end-joining. Telomere length is known to shorten with each round of cell division in most somatic cell types, a phenomenon linked to replicative senescence — the state in which a cell permanently stops dividing. Telomerase is the specialized enzyme capable of extending telomere length by adding repetitive sequence back onto chromosome ends, and its activity is tightly regulated, being largely suppressed in most differentiated adult somatic cells while remaining active in germline and certain stem cell populations. Epithalon’s primary research interest centers on its reported relationship to telomerase gene expression and activity in cultured cell models — a genuinely active area of ongoing investigation, examined using gene-expression assays and telomere-length measurement techniques such as quantitative PCR-based telomere assays.

Circadian and Pineal Signaling as a Research Framework

The second thread reflects Epithalon’s origin as a synthetic analog of a pineal-tissue peptide preparation. The pineal gland is the primary site of melatonin synthesis and plays a central role in circadian rhythm regulation. Research in this thread examines Epithalon’s reported relationship to circadian gene expression patterns and pineal signaling pathways in laboratory models, using clock-gene reporter assays and gene-expression profiling of core circadian regulatory genes. This thread connects Epithalon research to the broader field of chronobiology, in addition to its telomere-biology research association.

Why These Two Threads Are Studied Together

An emerging hypothesis in the broader aging-research literature connects circadian regulation and genomic stability mechanisms — including telomere maintenance — through shared upstream regulatory pathways, since core clock genes have been reported to influence expression of a range of downstream genes involved in cell-cycle regulation and DNA-damage response. Epithalon’s dual research association with both telomerase biology and circadian signaling positions it as a useful research tool for investigating that intersection specifically, rather than requiring separate compounds to probe each pathway independently.

Comparable Compounds in This Research Space

Researchers studying Epithalon’s telomere/circadian research angle frequently also investigate structurally related short bioregulator peptides studied for comparable pineal- and thymus-tissue-derived research associations. A dedicated comparison of Epithalon against one such compound is available in the Epithalon vs Thymalin peptide bioregulator comparison, and a broader treatment of the telomere-biology research field generally is available in telomeres, aging, and longevity peptides: research overview.

The Redox and Sirtuin Research Angle (NAD+)

NAD+’s research profile is built on a much older and more extensively characterized biochemical foundation than Epithalon’s, since NAD+’s core redox chemistry has been studied for the better part of a century as part of basic metabolic biochemistry. What has changed more recently is the intensity of research interest in NAD+ specifically as a variable in cellular-aging research, driven by its role as a shared, consumable substrate across several enzyme families implicated in age-related cellular regulation.

Mitochondrial Bioenergetics

NAD+ and its reduced counterpart NADH are central to the electron transport chain, the mitochondrial machinery responsible for the bulk of cellular ATP production via oxidative phosphorylation. Research examining the NAD+/NADH ratio, along with direct measurement of mitochondrial oxygen consumption rate and ATP output, is used to characterize mitochondrial functional capacity across research models — including comparisons across cell populations of different replicative or biological age, where mitochondrial function is a commonly examined variable.

Sirtuin Enzyme Research

Sirtuins are a family of NAD+-dependent deacetylase enzymes (SIRT1 through SIRT7 in mammalian systems) studied extensively for their role in regulating gene expression via histone and non-histone protein deacetylation, in mitochondrial biogenesis signaling, and in cellular stress-response pathways. Because sirtuins require NAD+ as an obligate cofactor to catalyze their deacetylase reaction, cellular NAD+ availability is studied as a potential rate-limiting factor for sirtuin activity — a research relationship that has motivated substantial interest in NAD+ itself, and in NAD+ precursor compounds, as research tools for probing sirtuin-dependent biology experimentally.

PARP and DNA Damage Response Research

Poly-ADP-ribose polymerases (PARPs) are enzymes activated in response to DNA strand breaks, and they consume NAD+ as a substrate for their poly-ADP-ribosylation activity. Research examining the relationship between DNA damage burden, PARP activation, and cellular NAD+ pool depletion represents a further research thread connecting NAD+ biochemistry to genomic stability research — a research area that, notably, creates a conceptual (though mechanistically distinct) point of contact with Epithalon’s telomere/genomic-stability research association discussed in the previous section.

NAD+ Precursor Compound Distinction

Researchers new to this space should note an important distinction: NAD+ itself, as supplied for research use, is different from NAD+ precursor compounds such as nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), which are metabolized through cellular salvage pathways to eventually produce NAD+, rather than supplying the coenzyme directly. Research protocols examining “NAD+ boosting” strategies broadly may use any of these related compounds, but they are not interchangeable at the level of mechanism — direct NAD+ administration to a cell culture system bypasses the salvage-pathway conversion steps that a precursor compound requires, which is a meaningful experimental-design consideration when interpreting or comparing results across studies using different NAD+-pathway compounds.

Where Research Interests Overlap: Senescence and Mitochondrial Aging Models

Despite their mechanistic divergence, Epithalon and NAD+ research programs intersect at several points, and understanding those intersections helps explain why the two compounds are frequently discussed within the same longevity-research conversation even though they are rarely functionally interchangeable in an experimental design.

Cellular Senescence as a Shared Research Endpoint

Cellular senescence — a state of stable cell-cycle arrest associated with characteristic gene-expression and secretory changes — is studied in relation to both telomere shortening (Epithalon’s primary research association) and mitochondrial dysfunction (NAD+’s primary research association). Because senescent cells frequently display both shortened telomeres and impaired mitochondrial function as concurrent features, senescence research protocols sometimes incorporate both telomere-length/telomerase-activity assays and NAD+/mitochondrial-function assays within the same study design, even when Epithalon and NAD+ themselves are not both administered as experimental variables — the overlap is at the level of the biological readout being studied, not necessarily at the level of which compound is being tested.

Mitochondrial-Nuclear Crosstalk Research

An active area of broader cellular-aging research examines communication between mitochondrial function and nuclear gene expression — sometimes described as mitochondrial-nuclear or mitochondrial-to-nuclear retrograde signaling. Because NAD+ availability affects sirtuin-mediated deacetylation of nuclear proteins (including histones, which directly influence gene expression), and because Epithalon’s proposed mechanism operates at the level of nuclear gene expression, research questions examining whether NAD+ pool status modulates the gene-expression pathways Epithalon is studied in connection with represent a genuinely open, actively investigated research intersection — one that a comparative research program might reasonably choose to examine directly, using both compounds in a matched experimental design.

Comparable Mitochondrial-Focused Peptide Research

Researchers interested in the mitochondrial side of this overlap may also want to review MOTS-c, a mitochondrial-derived peptide studied in relation to cellular energy metabolism, which shares conceptual research territory with NAD+ even though it is chemically a peptide rather than a coenzyme. Royal Peptide Labs maintains a dedicated MOTS-c vs NAD+ cellular energy research comparison, and a broader overview of mitochondrial-focused peptide research generally is available at mitochondrial peptides and cellular energy research.

Practical Guidance for Combined Study Designs

Where a study design incorporates both compounds, run each as an independent variable with its own control arm before considering any combined-exposure design, so that independent effects can be distinguished from any interaction effect.
Select assay readouts that are mechanistically appropriate to each compound rather than assuming a single readout (e.g., a generic “senescence marker panel”) captures the full relevant biology for both.
Document reconstitution, handling, and storage separately for each compound given their materially different stability profiles, discussed in the storage section below.
Be explicit in any resulting research write-up about which effects are attributed to which compound, particularly in combined-exposure designs where interaction effects can otherwise be difficult to disentangle from additive effects.

Analytical Purity: How Each Compound Is Verified

Because Epithalon and NAD+ belong to different chemical classes, they are verified analytically using overlapping but not identical methodology. Understanding those differences helps a research buyer interpret a certificate of analysis (COA) correctly for each compound.

Verifying Epithalon: Peptide-Standard HPLC and MS

As a synthetic peptide, Epithalon is verified using the same core analytical framework applied across the peptide research category generally: reverse-phase high-performance liquid chromatography (RP-HPLC) to establish purity — the proportion of the sample corresponding to the correctly synthesized, full-length AEDG sequence versus truncated or deletion-sequence byproducts from solid-phase synthesis — and mass spectrometry (typically electrospray ionization, ESI-MS) to confirm that the dominant HPLC peak corresponds to Epithalon’s expected molecular weight rather than a co-eluting synthesis byproduct of similar polarity.

Verifying NAD+: Chromatography and Spectroscopic Identity Confirmation

NAD+ is verified using chromatographic methods appropriate to a small, highly polar, charged dinucleotide molecule — commonly ion-pair or hydrophilic interaction liquid chromatography (HILIC) rather than the standard reverse-phase methods optimized for peptides, since NAD+’s charge and polarity profile behaves differently under reverse-phase conditions than a peptide chain does. UV-visible spectroscopy is also commonly used for NAD+ identity and concentration confirmation, since the molecule has a well-characterized absorbance profile, and mass spectrometry is used similarly to peptide verification, to confirm molecular identity against the expected mass. A rigorous COA for NAD+ should additionally address the oxidized (NAD+) versus reduced (NADH) proportion of the sample, since a research-grade NAD+ product should predominantly reflect the oxidized form rather than partially degraded material.

Purity Verification Comparison Table

Verification Parameter	Epithalon (peptide)	NAD+ (dinucleotide coenzyme)
Primary chromatographic method	Reverse-phase HPLC (RP-HPLC)	Ion-pair or HILIC chromatography
Identity confirmation method	Electrospray ionization mass spectrometry (ESI-MS)	Mass spectrometry plus UV-visible spectroscopic profiling
What purity % primarily reflects	Proportion of full-length AEDG sequence vs. truncated/deletion synthesis byproducts	Proportion of intact NAD+ vs. hydrolysis or degradation byproducts
Key degradation concern	Incomplete synthesis coupling; peptide bond hydrolysis (comparatively minor risk for a short chain)	Pyrophosphate bond hydrolysis; oxidized-to-reduced (NAD+ to NADH) state drift
Additional COA field to check	Full-length sequence confirmation	Oxidized (NAD+) vs. reduced (NADH) proportion of sample

Reading a COA for Either Compound

Regardless of compound class, a complete, lot-specific COA should include a lot or batch identifier, the relevant chromatographic purity result, mass spectrometry or spectroscopic identity confirmation, appearance and solubility notes, and the testing date and laboratory. Royal Peptide Labs publishes lot-specific documentation on its certificate of analysis (COA) page, and researchers should always cross-reference the COA against the specific lot number on the vial in hand rather than relying on a generic or previously issued document. A broader technical treatment of how HPLC and mass spectrometry function as complementary — not redundant — verification methods across the research peptide category is available in the quality testing overview, which applies to both compound classes discussed in this comparison.

Storage, Reconstitution, and Handling Differences

Because Epithalon and NAD+ have materially different chemical stability profiles, their laboratory handling requirements diverge in ways a research team should account for explicitly rather than assuming a single peptide-handling protocol applies equally to both.

Pre-Reconstitution Storage

Both compounds are supplied lyophilized and should be stored frozen, protected from light, and sealed against moisture exposure prior to reconstitution, consistent with standard practice for freeze-dried research biomolecules generally. NAD+ warrants somewhat closer attention to temperature consistency during storage, since its pyrophosphate linkage and the oxidized/reduced state balance of the molecule are more sensitive to thermal stress over extended storage periods than Epithalon’s peptide bonds are.

Reconstitution Considerations

Epithalon reconstitutes readily using standard peptide-research diluents, including bacteriostatic water, following the general reconstitution practice described in Royal Peptide Labs’ peptide storage and reconstitution guide — gentle diluent addition along the vial wall, gentle swirling rather than shaking, and visual confirmation of a clear solution free of particulate matter. NAD+ reconstitution requires additional attention to pH, since NAD+ stability in solution is pH-dependent, with the molecule generally more stable under mildly acidic to neutral conditions than under alkaline conditions; some research protocols additionally specify buffered diluents rather than plain water to help maintain solution pH within an appropriate stability range.

Post-Reconstitution Stability

Once reconstituted, both compounds should generally be stored refrigerated and used within the supplier-indicated stability window, but NAD+ solutions typically warrant more conservative handling — including minimizing time at room temperature during experimental preparation and avoiding repeated freeze-thaw cycling of reconstituted aliquots more strictly than may be necessary for a stable short peptide like Epithalon — given its comparatively greater susceptibility to hydrolytic and oxidative-state degradation in solution.

Storage and Handling Comparison Table

Handling Factor	Epithalon	NAD+
Lyophilized storage	Freezer, light-protected, sealed	Freezer, light-protected, sealed; tighter temperature consistency advised
Recommended diluent	Bacteriostatic or sterile water (standard peptide practice)	pH-appropriate diluent; buffered options sometimes specified
Reconstituted-solution sensitivity	Moderate; standard peptide-handling caution applies	Higher; more sensitive to pH, temperature, and hydrolysis
Freeze-thaw tolerance (reconstituted)	Limited repeated cycling generally advisable	Minimize repeated cycling more strictly; aliquot at reconstitution
Light sensitivity	Standard precaution	Standard to elevated precaution

The practical takeaway: a laboratory accustomed to routine peptide handling should not assume that experience transfers directly to NAD+ without adjustment. Building a short, compound-specific handling checklist — referencing each product’s own labeling and COA — is good practice whenever a research program works with both compound classes side by side.

Sourcing Considerations: What a Research Buyer Should Check

Sourcing quality matters for both compounds, but the specific documentation and quality signals a research buyer should look for differ somewhat given their distinct chemistry.

Lot-Specific Documentation for Both Compound Classes

Regardless of compound type, a supplier serious about supporting legitimate research should make lot-specific COAs readily accessible and tied to the exact lot number printed on the vial received, not a generic or reused specification sheet. Researchers evaluating either Epithalon or NAD+ sourcing may find it useful to review the general guidance in what to look for in research peptide purity documentation before comparing suppliers, since the underlying documentation-transparency principles apply across both compound classes even though the specific analytical methods differ.

Compound-Specific Documentation to Confirm

For Epithalon: confirmation of the correct AEDG sequence (not simply a peptide of the correct molecular weight, which could theoretically reflect a different sequence with similar mass), HPLC purity percentage, and mass spectrometry identity confirmation.
For NAD+: confirmation of oxidized-form (NAD+, not primarily NADH or degraded material) purity, chromatographic purity percentage using a method appropriate to the molecule’s polarity, and mass spectrometry or spectroscopic identity confirmation.

Packaging and Cold-Chain Practices

Because NAD+ is comparatively more stability-sensitive than a short, stable peptide like Epithalon, appropriate packaging and shipping practices that minimize thermal excursion in transit carry somewhat greater importance for NAD+ specifically — though both compounds benefit from light-protected, properly sealed vial packaging and labeling that clearly indicates lot number, research-use-only status, and storage requirements upon receipt.

Research-Use-Only Framing

As with any compound in this research category, a supplier’s labeling and marketing language is itself a quality signal. Suppliers that frame both Epithalon and NAD+ strictly around research applications, avoid therapeutic or outcome-based claims, and clearly state research-use-only status are more likely to be operating within a compliance framework appropriate for this category.

Supplier Evaluation Checklist

Evaluation Criterion	What to Look For
Lot-specific COA availability	Published or easily requestable, tied to the exact lot received, for both product lines
Compound-appropriate testing methodology	RP-HPLC/MS for Epithalon; HILIC/ion-pair chromatography plus MS or UV-vis for NAD+
Labeling accuracy	Research-use-only stated clearly for both products; no therapeutic claims
Storage/shipping practices	Appropriate packaging; extra care for NAD+’s greater thermal/pH sensitivity
Product-specific documentation	Specifications matched to the exact SKU — the Epithalon 10mg listing and the NAD+ 500mg listing — not a generic catalog entry

Choosing Between Epithalon and NAD+ for a Study Design

Given everything covered above, the practical question most research teams actually need answered is simple: given a specific research question, which compound is the more appropriate research tool — or does the question call for both, studied independently or in combination?

Framework for the Decision

The clearest decision heuristic returns to the mechanistic-layer distinction introduced earlier in this guide: questions centered on gene expression, telomere maintenance, or circadian signaling point toward Epithalon; questions centered on redox biochemistry, mitochondrial bioenergetics, or sirtuin/PARP substrate availability point toward NAD+. Questions that genuinely span both layers — such as investigations into mitochondrial-nuclear signaling crosstalk in a senescence model — may reasonably call for a combined design using both compounds as independent variables.

Research Question Fit Table

Research Question Type	Better-Fit Compound	Why
Telomerase gene expression / telomere length in cultured cells	Epithalon	Directly aligned with Epithalon’s primary research association
Circadian clock-gene expression rhythms	Epithalon	Aligned with its pineal-analog research origin
Mitochondrial oxygen consumption / respiratory function	NAD+	NAD+/NADH cycling is central to electron transport chain function
Sirtuin deacetylase enzymatic activity	NAD+	NAD+ is an obligate cofactor for sirtuin catalytic activity
PARP-mediated DNA damage response signaling	NAD+	PARPs consume NAD+ as a substrate during activation
Cellular senescence phenotype (combined markers)	Both, as independent variables	Senescent cells display both telomere and mitochondrial changes concurrently
Mitochondrial-to-nuclear signaling crosstalk	Both, potentially in combination	Spans both the redox/substrate layer and the gene-expression layer

When a Combined Design Makes Sense

A combined study design — testing Epithalon and NAD+ as independent variables within the same broader research program, even if not administered together in the same treatment arm — is most justified when the underlying research question explicitly concerns the relationship between the two mechanistic layers, rather than simply because both compounds are categorized under a shared “longevity” label. Research teams should resist the temptation to combine compounds purely on the basis of category adjacency; a well-justified combined design should be able to articulate, in advance, a specific hypothesis about how the two pathways are expected to interact.

When a Single-Compound Design Is More Appropriate

Conversely, many legitimate research questions are cleanly answered with a single compound and a well-designed dose-response or time-course protocol against appropriate controls, without introducing the added complexity and interaction-effect ambiguity of a two-compound design. Simplicity in experimental design is generally preferable when the research question does not specifically require examining an interaction between the two mechanistic layers this comparison has described.

Common Research Questions About Epithalon and NAD+

Beyond mechanism and sourcing, research teams working with either or both compounds frequently encounter a recurring set of practical, experimental-design questions. This section addresses the most common of them directly.

Can Epithalon and NAD+ Be Studied in the Same Cell Culture System?

Yes, in principle — both are studied across standard cultured cell line systems, and there is no inherent chemical incompatibility that would prevent a research design from examining both compounds within the same broader cell-culture research program, whether in separate treatment arms or, where the hypothesis specifically warrants it, in combination. As noted above, any combined-exposure design should include appropriate single-compound control arms to allow independent and interaction effects to be distinguished.

Are There Established Reference Standards for Comparative Work?

For Epithalon, reference standards typically include other short bioregulator peptides studied in comparable telomere or pineal-signaling research contexts, such as thymalin-class peptides. For NAD+, reference standards typically include NAD+ precursor compounds (such as NMN or NR) for studies examining differences between direct NAD+ supplementation and salvage-pathway-dependent precursor conversion, or other mitochondrial-support research compounds such as MOTS-c for broader cellular-energy comparative work.

How Should a Research Team Characterize a New Lot of Either Compound Before Use?

Before layering any experimental question on top of a newly received lot of either compound, a baseline characterization step is advisable: confirm the COA’s chromatographic and identity data against the specific lot in hand, perform a visual and solubility check upon reconstitution, and, where feasible, run a basic confirmatory assay — such as a simple gene-expression check for Epithalon or a basic NAD+/NADH ratio measurement for NAD+ — against a known reference standard before committing the lot to a larger study.

What Are Common Sources of Cross-Laboratory Variability?

For Epithalon, cross-laboratory variability commonly stems from differences in cell line passage number, differences in reconstitution and handling practice, and differences in the specific gene-expression assay technology used. For NAD+, variability commonly stems from differences in sample handling time before measurement (given NAD+’s comparative instability), differences in the specific chromatographic or enzymatic-cycling assay method used to quantify NAD+/NADH, and differences in how tightly a laboratory controls pH and temperature during sample processing.

How Should Unexpected Results Be Interpreted?

An unexpected or null result involving either compound should prompt review of compound handling and lot documentation before being interpreted as a genuine biological finding — particularly given NAD+’s comparative stability sensitivity discussed throughout this guide. Confirming COA data against the specific lot, checking reconstitution and storage history, and, where practical, re-testing with a freshly reconstituted aliquot are reasonable first steps before concluding that an unexpected result reflects true biological signal rather than a handling artifact.

Frequently Raised Experimental Design Questions

Question	Design Consideration
Which compound fits a telomere-length study?	Epithalon — directly aligned with its telomerase-related research association
Which compound fits a mitochondrial-function study?	NAD+ — directly tied to redox and electron-transport-chain biochemistry
How to reduce lot-to-lot variability in longitudinal studies?	Source multiple study aliquots from the same verified lot where the study timeline allows, for either compound
How to document handling for reproducibility?	Log reconstitution date, diluent, freeze-thaw count, and storage temperature history per aliquot, per compound

Safety and Handling Protocols for Laboratory Personnel

Because both Epithalon and NAD+ are supplied strictly for in-vitro laboratory and research use, handling practices should follow standard laboratory biosafety and chemical-handling protocols applicable to bioactive research compounds generally — the same rigor applied to any research compound, not an elevated or unique protocol for either.

Personal Protective Equipment

Standard laboratory PPE — gloves, eye protection, and a lab coat — should be worn when handling either compound in lyophilized or reconstituted form, consistent with an institution’s standard operating procedures for bioactive compound handling. Because lyophilized powder of either compound can become airborne during handling, particularly when opening vials, work should be conducted in a manner that minimizes aerosolization, such as within a fume hood or biosafety cabinet where institutional protocols call for it.

Spill and Waste Handling

Spilled lyophilized material or reconstituted solution of either compound should be handled according to institutional chemical waste protocols. Neither compound should be treated as biologically inert for disposal purposes given their bioactive research roles — institutional environmental health and safety guidance should govern disposal of both waste solution and any contaminated consumables.

Labeling and Chain-of-Custody Practices

Reconstituted stock solutions and working dilutions of either compound should be clearly labeled with compound identity, concentration, reconstitution date, and preparer initials at minimum. This takes on particular importance where a laboratory keeps both Epithalon and NAD+ on hand simultaneously alongside other longevity-research compounds, since mislabeling risk increases with the number of structurally and visually similar lyophilized vials a laboratory stores in close proximity.

Research-Use-Only Scope Boundaries

All handling, storage, and experimental use of Epithalon and NAD+ sourced through Royal Peptide Labs should remain within the bounds of in-vitro laboratory and research applications. This guide does not provide, and should not be interpreted as providing, guidance for any application outside that scope. Laboratory personnel and institutional oversight bodies, such as an Institutional Biosafety Committee where applicable, should be consulted regarding any institution-specific requirements that go beyond the general practices summarized here.

Documentation for Reproducibility

Record reconstitution date and diluent lot alongside each compound’s own lot number, tracked separately for Epithalon and NAD+.
Track number of freeze-thaw cycles for any aliquoted, reconstituted solution — with particular diligence for NAD+ given its comparative instability.
Note storage temperature excursions if a freezer or refrigerator event is logged during either compound’s storage window.
Retain the COA associated with each lot of each compound alongside experimental records for that lot, not filed separately where it may become disconnected from the data it supports.

The Longevity Peptide and Coenzyme Research Landscape in 2026

Longevity-focused cellular research has expanded considerably in recent years, and both telomere/circadian-focused peptide research and NAD+/sirtuin-focused coenzyme research sit within that broader expansion as of 2026, even though they represent distinct sub-fields with their own methodological traditions and open questions.

Growing Interest in Multi-Pathway Aging Research

The general trajectory of cellular-aging research has moved from single-pathway characterization toward increasingly integrated, multi-pathway investigation — a trend reflected in the growing research interest in how telomere biology, circadian signaling, mitochondrial bioenergetics, and sirtuin-mediated gene regulation interact rather than operate in isolation. This shift reflects a broader hypothesis gaining traction across the aging-research field: that cellular aging is unlikely to be explained by any single mechanism, and that research tools addressing complementary pathways — such as Epithalon and NAD+ together — may be increasingly valuable for modeling that complexity experimentally.

Expanding Comparative and Combinatorial Literature

As more longevity-focused research compounds enter active investigation, the comparative and combinatorial literature — studies explicitly designed to compare mechanistically distinct compounds like Epithalon and NAD+, or to examine their combined effects within a single research design — is expanding accordingly. This mirrors a pattern seen across other research-peptide categories, where the field matures from establishing that a compound is bioactive at all toward more granular, comparative, and mechanistically integrated research questions.

Methodological Advances Supporting This Research

Advances in assay technology — including more sensitive mass-spectrometry-based NAD+/NADH quantification methods, improved single-cell gene-expression profiling techniques applicable to telomerase and circadian-gene research, and more sophisticated live-cell imaging for tracking mitochondrial function alongside nuclear signaling in real time — have made it increasingly feasible to study Epithalon’s and NAD+’s respective pathways with a level of mechanistic resolution that would have been impractical even a research generation earlier.

Where Research Appears to Be Heading

Within this research space specifically, ongoing directions include finer characterization of the mitochondrial-nuclear signaling crosstalk discussed earlier in this guide, continued refinement of chromatographic methods for both peptide and dinucleotide purity verification at increasingly rigorous standards, and growing interest in systematic, matched comparative study designs that place mechanistically distinct longevity-research compounds like Epithalon and NAD+ side by side under controlled conditions. Research laboratories tracking this space should expect continued growth in the published, searchable literature base — the references section below links directly to searchable PubMed and ClinicalTrials.gov queries that will surface new entries as they are indexed, rather than relying on any static summary that would inevitably become outdated.

Staying Current as a Research Buyer

Given how quickly this research area is moving, laboratories sourcing either compound for ongoing programs are well served by periodically revisiting supplier documentation, periodically re-running the PubMed and ClinicalTrials.gov searches referenced at the end of this guide, and maintaining relationships with suppliers who demonstrate ongoing investment in testing rigor rather than a one-time compliance posture. Royal Peptide Labs’ broader longevity and cellular peptides research category is a reasonable starting point for tracking adjacent compounds as the field continues to develop.

Frequently Asked Questions

What is the core difference between Epithalon and NAD+?

Epithalon is a synthetic four-amino-acid peptide studied primarily in connection with telomerase gene expression and circadian/pineal signaling, while NAD+ is a naturally occurring dinucleotide coenzyme studied primarily in connection with mitochondrial redox metabolism and as a required substrate for sirtuin and PARP enzymes. They belong to entirely different chemical classes and are investigated at different biological layers — gene regulation versus metabolic biochemistry.

Is NAD+ a peptide like Epithalon?

No. NAD+ is a dinucleotide coenzyme built from two nucleotide units joined by a pyrophosphate linkage, chemically unrelated to peptide chemistry. Epithalon is a four-residue peptide assembled from standard amino acids via solid-phase peptide synthesis. Both are cataloged in the same longevity research category for research-program convenience, not because they share a chemical class.

Can Epithalon and NAD+ be studied together in the same research protocol?

Yes, in principle. There is no inherent chemical incompatibility, and some research questions — particularly those examining mitochondrial-to-nuclear signaling crosstalk — may specifically call for a combined design using both compounds as independent variables with appropriate single-compound control arms.

Which compound is more relevant to a telomere-length study?

Epithalon is the more directly relevant research tool for telomere-length and telomerase gene-expression studies, since that pathway is its primary research association. NAD+’s research relevance centers on redox biochemistry and enzymatic substrate availability rather than telomere maintenance directly.

Which compound is more relevant to a mitochondrial-function study?

NAD+ is the more directly relevant research tool for mitochondrial bioenergetics and redox-function studies, given its central role in the electron transport chain and as a cofactor for sirtuin enzymes linked to mitochondrial biogenesis signaling.

Are Epithalon and NAD+ verified using the same analytical methods?

Not exactly. Epithalon is verified using standard peptide analytical methods — reverse-phase HPLC and mass spectrometry. NAD+ is verified using chromatographic methods suited to a small, polar dinucleotide molecule, such as ion-pair or HILIC chromatography, often paired with UV-visible spectroscopy and mass spectrometry, and a rigorous NAD+ COA should also address the oxidized-versus-reduced state proportion of the sample.

Is NAD+ the same as NMN or NR?

No. NAD+ is the coenzyme itself, while NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursor compounds that cells convert into NAD+ through salvage biosynthetic pathways. Direct NAD+ administration to a research system bypasses those conversion steps, which is a meaningful distinction for experimental design and for interpreting results across studies using different NAD+-pathway compounds.

How should Epithalon and NAD+ be stored before use in a lab?

Both are typically supplied lyophilized and should be stored frozen, protected from light, and sealed against moisture prior to reconstitution. NAD+ generally warrants closer attention to temperature consistency and, once reconstituted, to pH and minimizing freeze-thaw cycling, given its greater sensitivity to hydrolytic and oxidative-state degradation compared to a short, stable peptide like Epithalon.

Why are Epithalon and NAD+ both categorized as longevity research compounds?

Both are studied in connection with cellular-aging biology, even though they operate through mechanistically distinct pathways — Epithalon through gene-expression and genomic-stability research, NAD+ through metabolic and enzymatic-substrate research. The shared category reflects the research theme, not a shared mechanism or chemical class.

Where can researchers find current, verifiable literature on Epithalon and NAD+?

The most reliable approach is to search PubMed and ClinicalTrials.gov directly using the search links provided in the references section of this guide, since these databases are continuously updated and avoid the risk of relying on any static, potentially outdated summary of the literature.

Scientific References

The following are live search links into PubMed and ClinicalTrials.gov, rather than citations to specific papers, so that researchers always land on the current, indexed literature rather than a static and potentially outdated reference list.

All products and information from Royal Peptide Labs are intended strictly for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.